Webinar Recap: Corticosteroids in COVID-19; defining best practices in Africa

As part of our commitment to supporting the African clinical care and research community through the COVID-19 pandemic, Pharmacometrics Africa recently participated in organizing a webinar covering the use of corticosteroids in the treatment of COVID-19. This meeting was hosted by the African Academy of Sciences (AAS) on behalf of the New Partnership for Africa’s Development (AUDA-NEPAD), African Coalition for Epidemic Research, Response and Training (ALERRT), Africa Centres for Disease Control and Prevention (AFRICA CDC) and the World Health Organization Regional Office for Africa (WHO Afro). These organizations continue to collaborate in the effort to fight COVID-19 across Africa.

Moderated by John Amuasi of Kwame Nkrumah University (Ghana) and Francine Ntoumi of the Congolese Foundation of Medical Research (Congo), who catered to the English and French delegates attending the webinar, the following objectives were covered:

  • provide up-to date information on evidence of the effectiveness and safety of corticosteroids in COVID-19

  • identify key questions for translating clinical trial evidence on the use of corticosteroids in COVID-19 into clinical practice in Africa

  • gather input into translational research agenda to ensure guidance on corticosteroid use in COVID-19 is adapted to African standards

If you'd like to view the webinar in its entirety, review the presentation slides or view a brief overview of what was discussed, please use the links below: Webinar Video Webinar Slides Webinar Report / Overview

We look forward to supporting future efforts to review, disseminate and share critical information through the pandemic.

Recent Posts

See All

© 2020 Pharmacometrics Africa NPC :: Privacy Policy